ASCO 2022
ASCO22: Enhertu aces key HER2-low test in breast cancer
Phil Taylor
ASCO 2022, AstraZeneca, breast cancer, Daiichi Sankyo, Enhertu, Oncology
0 Comment
X
ASCO22: Enhertu aces key HER2-low test in breast cancer
https://pharmaphorum.com/news/asco22-enhertu-aces-key-her2-low-test-in-breast-cancer/
ASCO22: Gilead makes case for Trodelvy in advanced breast cancer
Phil Taylor
ASCO 2022, breast cancer, Gilead Sciences, Oncology, Trodelvy
0 Comment
X
ASCO22: Gilead makes case for Trodelvy in advanced breast cancer
https://pharmaphorum.com/news/asco22-gilead-makes-case-for-trodelvy-in-advanced-breast-cancer/
Oncology/ Views & Analysis/ Views and analysis
ASCO ’22 preview: Putting patients first
Jonah Comstock
asco, ASCO 2022, ASCO preview, IQVIA
0 Comment
X
ASCO ’22 preview: Putting patients first
https://pharmaphorum.com/views-analysis-oncology/asco-22-preview-putting-patients-first/